For decades, medical researchers have relied on animal models or rigid, plastic pumps to simulate the human heart. These tools are often poor substitutes for the real thing, failing to capture the complex, twisting mechanics of a muscle that beats 100,000 times a day.

Now, a team at UNSW Sydney has bridged that gap. They have developed a fully synthetic, soft robotic model of the left side of the human heart that doesn't just pump fluid—it mimics the intricate, layered architecture of human muscle tissue. By using silicone membranes and hydraulic artificial muscles, the team has created a device capable of reproducing the specific, often lethal, mechanics of heart disease.

Why the Timing Matters

Cardiovascular disease remains the world’s leading cause of death, yet developing effective treatments is notoriously difficult. Conditions like heart failure with preserved ejection fraction (HFpEF) manifest differently in every patient, often complicated by comorbidities like diabetes or kidney disease.

This new model, detailed in Nature Communications and Advanced Science, allows researchers to test next-generation cardiac devices in a realistic environment before they ever reach a human patient. By recreating the internal structures of the heart—including the papillary muscles and chordae tendineae—the team can simulate how valves fail, leak, or stiffen under pressure. This level of precision could eventually reduce the industry's reliance on animal testing while providing surgeons with patient-specific models to rehearse complex procedures.

Mimicking the Heart’s 'Swinging Doors'

At the heart of the model is the mitral valve, which acts as a set of swinging doors to ensure oxygen-rich blood flows in only one direction. In a diseased heart, these doors can fail, leading to regurgitation, where blood leaks backward and forces the heart to work harder, eventually leading to failure.

"We found a way to model this muscle fibre architecture using soft robotic artificial muscle fibres," says Dr. James Davies, a postdoctoral researcher in the lab. "They are powered by hydraulic pressure which we control to make our ventricular muscle model move like the real thing."

By actively adjusting the tension in the artificial papillary muscles, the researchers can induce specific pathologies, such as mitral valve prolapse. Because the model is compatible with standard clinical tools like echocardiography, the team was able to validate their results by comparing the "robot's" pressure and flow waveforms against those of a healthy human heart.

Key Takeaways

  • High-Fidelity Simulation: The model uses hydraulic artificial muscles to replicate the twisting, layered contraction of human heart tissue, a significant upgrade over rigid laboratory pumps.
  • Disease Modeling: Researchers can adjust the tension of artificial papillary muscles to simulate specific conditions like mitral valve regurgitation and prolapse.
  • Clinical Compatibility: The device is designed to work with standard medical imaging, such as ultrasound, allowing for direct comparison between the model and real-world patient data.

What Experts Say

Scientia Associate Professor Thanh Nho Do, who led the research, emphasizes that the goal is to move toward more personalized care. "Because it affects people in different ways, developing medical devices to improve heart function is challenging," Do explains. By creating a platform that can be tuned to mimic a specific patient's anatomy, the team hopes to provide a sandbox for doctors to plan treatments before stepping into the operating room.

As the team refines the model, the next phase will involve integrating it into clinical workflows. The ability to test a device against a patient's own simulated heart mechanics could change how surgeons approach high-risk valve repairs. The technology is currently in the research phase, but as it matures, it promises to turn the trial-and-error nature of cardiac device development into a more predictable, data-driven process.